87 studies found for:    Leigh's Disease
Show Display Options
RSS Create an RSS feed from your search for:
Leigh's Disease
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome
Condition: Leigh Syndrome
Interventions: Drug: Placebo;   Drug: EPI-743 15 mg/kg;   Drug: EPI-743 5 mg/kg
2 Enrolling by invitation Long-Term Safety and Efficacy Evaluation of EPI-743 in Children With Leigh Syndrome
Condition: Leigh Syndrome
Intervention: Drug: EPI-743
3 Recruiting Tissue Sample Study for Mitochondrial Disorders
Conditions: Mitochondrial Disorders;   Mitochondrial Disease;   Melas;   Kearns Sayer;   NARP;   MNGIE;   LHON;   Mitochondrial Depletion Syndrome;   Leigh's Disease
Intervention:
4 Recruiting Open-Label, Dose-Escalating Study to Assess Safety, Tolerability, Efficacy, PK and PD of RP103 in Children With Inherited Mitochondrial Disease
Condition: Inherited Mitochondrial Disease, Including Leigh Syndrome
Intervention: Drug: Cysteamine Bitartrate Delayed-release Capsules (RP103)
5 Recruiting North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Conditions: Mitochondrial Disorders;   Mitochondrial Genetic Disorders;   Mitochondrial Diseases;   Disorder of Mitochondrial Respiratory Chain Complexes;   Deletion and Duplication of Mitochondrial DNA
Intervention:
6 Active, not recruiting EPI-743 for Mitochondrial Respiratory Chain Diseases
Condition: Mitochondrial Diseases
Intervention: Drug: EPI-743
7 Completed Stalevo in Early Wearing-Off Patients
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Stalevo (levodopa/carbidopa/entacapone);   Drug: Levodopa/carbidopa
8 Completed Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)
Conditions: Gastroesophageal Reflux;   GERD;   GORD
Intervention: Drug: Pantoprazole
9 Completed Effect of Dietary Salicylate in Aspirin Exacerbated Respiratory Disease
Conditions: Chronic Rhinosinusitis;   Aspirin Exacerbated Respiratory Disease;   Asthma;   Aspirin Sensitivity
Intervention: Behavioral: Low salicylate diet
10 Completed
Has Results
Atomoxetine and Huntington's Disease
Conditions: Huntington Disease;   Chorea
Interventions: Drug: atomoxetine;   Drug: Matching Placebo
11 Active, not recruiting A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease
Condition: Moderate Risk of CVD
Interventions: Drug: Aspirin (Acetylsalicylic acid, BAYE4465);   Drug: Placebo
12 Completed
Has Results
Citalopram to Enhance Cognition in HD
Conditions: Huntington Disease;   Chorea;   Executive Dysfunction
Interventions: Drug: 20mg daily citalopram;   Drug: Placebo
13 Completed Providing Resources to Enhance African American Patients' Readiness to Make Decisions About Kidney Disease (PREPARED) Study
Conditions: End Stage Renal Disease (ESRD);   Chronic Kidney Disease (CKD)
Intervention: Behavioral: Information
14 Active, not recruiting Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Condition: Arthritis, Rheumatoid
Interventions: Drug: celecoxib;   Drug: Ibuprofen;   Drug: Naproxen
15 Completed A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder
Interventions: Drug: ALKS 5461;   Drug: Placebo
16 Active, not recruiting Long-term Lung Function and Disease Progression in Children With Early Onset Primary Ciliary Dyskinesia Lung Disease
Condition: Kartagener Syndrome
Intervention:
17 Completed Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.
Condition: Anxiety Neuroses
Intervention: Drug: Pregabalin
18 Completed Evaluation of the Active Living Every Day Exercise Program for People With Arthritis
Condition: Arthritis
Intervention: Behavioral: Active Living Every Day
19 Completed ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD
Condition: Major Depressive Disorder
Interventions: Drug: ALKS 5461;   Drug: Placebo
20 Recruiting A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).
Condition: Rheumatoid Arthritis
Interventions: Biological: PF-06438179;   Biological: Infliximab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years